Aubrey de Grey Longevity World Forum

Aubrey de Grey announces that age-reversing medication will be a reality in five years from now

The researcher Aubrey de Grey is well known for his strong advocacy that an indefinite life expectancy is possible. He will present his ideas on the 7th and 8th of November in Valencia where the first edition of the Longevity World Forum will take place. This meeting on longevity, genomics and precision is the first of its kind in the world. In addition, the biomedical gerontologist will prove that we are closer to achieving indefinite longevity than we think. “The next key step will take place when results in labs with mice are sufficiently impressive so that people start realising that medicines to keep us young will actually come soon. I would dare to say that in just five years from now.”, he says.

Aubrey de Grey also believes that treatments to conquer death will be accessible to everybody.  As he said, “They will be absolutely available to all those old enough to need them. This will be economically feasible because the elderly population will keep active instead of becoming an expense. In addition, these medicines will be developed, at least one decade before they are perfected, hence both governments and industries will have time to implement the necessary changes to ensure that there are no delays in providing universal access.

Reservations have been expressed about Aubrey de Grey’s ideas both from the scientific and social point of view, as well as due to its impact on the sustainability of the planet. However, he counters criticism with his conviction that the consequences of human longevity are not worrying. “It is only possible to think that this would be an issue if all the technologies that are being developed even before rejuvenation, which will reduce pollution, are ignored. Once we have ubiquitous renewable energy, artificial meat, and desalinization, all very cheap, more people will be able to inhabit the Earth with a lower environmental impact than nowadays“, he explains.

Aubrey de Grey’s perspective comes from his concept of the human body, which he conceives as some sort of machine. “We need a comprehensive preventive maintenance strategy. This way, we will get rid of the harm that our own functioning produces before it is too much and we become ill. The only problem is that we still have not developed all the technology that allows us to do so, but we are close!”, he says.

Whether you agree or not with him, the truth is that he captures everybody’s attention. The Longevity World Forum is the first European conference on longevity, genomics and precision medicine where Audrey de Grey will participate. The conference will be held in the Valencia Conference Centre on the 7th and 8th of November with the participation of world leaders of the scientific community such as María Blasco, head of the Spanish National Cancer Research Centre; Ángela Nieto, head of the Developmental Neurobiology Unit of the UMH-CSIC Neuroscience Institute located in Alicante; Manuel Corpas, CEO and founder of Cambridge Precision Medicine; Lissette Otero, Chief Medical Officer and Laboratory Director in Life Length; and Maria Chatzou, CEO of Lifebit, among others. Tickets are still available on the official website www.longevityworldforum.com.

Calico-Longevity-World-Forum-Valencia-2018

Calico, Google’s biotech company, joins the Longevity World Forum

The pioneering nature and professional approach of the Longevity World Forum is attracting the attention of different actors involved in the fields of longevity, genomics and precision medicine. Less than two months away from the first edition, the event has gained the support of Calico, a biotech company that, under the umbrella of Google, works in the research and development of this field.

The organizers of the #Longevity18 have stated “it is great news that a company such as Calico joins the Longevity World Forum for several reasons. It reflects the need to hold an event such as this one which addresses an issue that affects the society as a whole. In addition, as a result, everyone interested in scientific and medical development will have their eyes on Spain in general and on Valencia in particular”.

Ever since Calico was established in 2013, the company has focused on combating ageing and associated diseases. In order to do so, it has a multidisciplinary team of scientists from the fields of medicine, genetics and molecular biology, among others. Calico aims at providing the environment to support innovation and improve human health, as the company explains.

El Longevity World Forum has been conceived as a project that serves this mission, that is, an event that becomes a meeting point to pool knowledge and create synergies to extend life expectancy and improve life quality. Hence, world leaders of the scientific community will gather together in the Valencia Conference Centre on the 7th and 8th of November.

Among others, the following renowned professionals will take part in Longevity World Forum: Aubrey de Grey, biomedical gerontologist and founder of SENS Research Foundation; María Blasco Marhuenda, head of the Spanish National Cancer Research Centre; José Viña and Federico Pallardó, Professors of Physiology at the University of Valencia; Ángela Nieto, head of the Developmental Neurobiology Unit of the UMH-CSIC Neuroscience Institute located in Alicante; Manuel Pérez Alonso, Professor of Genetics at the University of Valencia; Manuel Corpas, CEO and founder of Cambridge Precision Medicine; Lissette Otero, Chief Medical Officer and Laboratory Director in Life Length; and Maria Chatzou, CEO of Lifebit.

#Longevity18 is an initiative promoted by the consulting firm Talentum Group in collaboration with the agency Medigene Press, which publishes the journal Genética Médica News, as well as the international company Cambridge Precision Medicine. Tickets are limited but they are still available on the official website www.longevityworldforum.com. Those interested in attending the event who can provide evidence that they belong to an academic institution or a professional association will receive special discounts.

Longevity 2018 Participantes

Valencia is getting ready to welcome world leaders of the scientific community to the Longevity World Forum

The Longevity World Forum will be held soon in the Conference Centre on the 7th and 8th of November. The city of Valencia will become a meeting point for the scientific community, both at a national and international level, since this is the first gathering in Europe that will address topics of current interest such as longevity, genomics and precision medicine.

#Longevity18 is an initiative promoted by the consulting firm from Valencia Talentum Group; the company Medigene Press, which publishes the journal Genética Médica News; and the international company Cambridge Precision Medicine. The organizing partners explain that the purpose of this event is to create a meeting point for all the actors involved in the study of life expectancy and improvement of the quality of life. Therefore, the Longevity World Forum is open to all students, scientific researchers, and professionals from the healthcare, pharmacy and biotechnology industry. The conference agenda has been designed to pool all the existing knowledge on the latest achievements and to create synergies that allow the scientific community to face the numerous challenges of the immediate future.

The interest generated by the Longevity World Forum is not surprising given its panel of high-level participants. Among others, the following renowned professionals will take part in Longevity World Forum: Aubrey de Grey, biomedical gerontologist and founder of SENS Research Foundation; María Blasco Marhuenda, head of the Spanish National Cancer Research Centre; José Viña and Federico Pallardó, Professors of Physiology at the University of Valencia; Ángela Nieto, head of the Developmental Neurobiology Unit of the UMH-CSIC Neuroscience Institute located in Alicante; Manuel Pérez Alonso, Professor of Genetics at the University of Valencia; Manuel Corpas, CEO and founder of Cambridge Precision Medicine; Lissette Otero, Chief Medical Officer and Laboratory Director in Life Length; and Maria Chatzou, CEO of Lifebit.

Tickets for the first edition of Longevity World Forum are limited and available on the official website: www.longevityworldforum.com. Those interested in attending the event who can provide evidence that they belong to an academic institution or a professional association will receive special discounts.

Mercedes Aguirre Lipperheide

Nua Biological Innovations SL

Mercedes Aguirre Lipperheide was born in Getxo (Vizcaya, Spain) in 1966. Following her degree in Marine Biology (University of La Laguna, Tenerife) she went on to do her PhD at Leeds University (Pure & Applied Biology Dpt.- UK, 1993). For 24 years her activities have focused on health-related issues, nutrition and supplementation, with special emphasis on the field of prevention. For the last 10 years she has been leading Nua Biological Innovations SL, a laboratory dedicated to the elaboration of food supplements. She is also involved in applied research projects with public and private institutions and has also been a lecturer in various forums related to the above mentioned fields. She has published 4 books related to these topics (www.mercedesaguirre.com).